InvestorsHub Logo
Followers 314
Posts 24877
Boards Moderated 9
Alias Born 10/26/2008

Re: None

Wednesday, 04/07/2021 6:07:50 AM

Wednesday, April 07, 2021 6:07:50 AM

Post# of 171
#vaccinex $VCNX Conclusions: The combination of pepinemab with avelumab was well tolerated in NSCLC and showed signs of antitumor activity in immunotherapy resistant and PD-L1 negative / low tumors.
Down pointing backhand index
5 april 2021!!!

https://clincancerres.aacrjournals.org/content/early/2021/04/02/1078-0432.CCR-20-4792


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCNX News